Comparative Study between Yoni Dhavan, Oral Medicine and both therapy in the treatment of Swetapradara
Abstract
Swetapradara is a common and major problem in our country of female especially reproductive age. Total patients (60) were divided into three group i.e. Gr-A, Gr- B and Gr- C with clinical features of white vaginal discharge, itching of vulva, burning pain in vagina, low back pain, general weakness.Gr-A was treated with Yoni Dhavan (Vaginal irrigation) by a compound decoction. Gr- B was treated with oral medicine by Pusyanuga Churan.Gr- C was treated with both therapies i.e., Yoni Dhavan & Oral medicine. This comparative clinical trial was conducted to evaluate the efficacy of Gr-C which were confirmed that the effectiveness was better than other groups in the management of Swetapradara. This study observe a highly significant reduction in mean scores of clinical feature and overall compliance to the treatment was excellent in the Gr-C and p value of < 0.001 was considered highly significant.
Downloads
References
Prof.K.R.Srikanth Murthy, Astanga Samgraha of Vagbhata, Vol- iii, Uttarsthana, 4th edition, Chaukhambha Orientalia, Varanasi, 2005,pp- 347.
Shri Gobinda Dasji, Bhaisajya Ratnavali, Vol-iii, 1st edition, Chaukhambha Sanskrit Bhawan, Varanasi, 2006, pp-343.
Govt. of India, The Ayurvedic Formulary of India, (part-1), First edition, Government of India press, Faridabad, 1978, pp- 91-92.
Copyright (c) 2022 Animesh Maiti
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.